...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distribution
2
Oct 23, 2023 05:17PM

Koo,

With all the trials being paid for by the BP  trial collaborations and Health care institutions where is all that $23 Million  going towards,  I can't imagine salary and admin costs and rents  are even close to that amount ??? 

Share
New Message
Please login to post a reply